fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65. - cGMP deviations.

Source: FDA | Recall date: 05/06/2026

Don't want to manually check every recall?

Track your baby products and get automatic recall alerts when something may affect your family.

Start Free Recall Tracking How Recall Alerts Work

Learn more about the baby product recall tracker, baby product recall alerts, or recall monitoring plans.

Affected product: fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65.

Summary: cGMP deviations.

Hazard: cGMP deviations.

Open Official Recall Notice Back to Home

Don't want to manually check every recall?

Track your baby products and get automatic recall alerts when something may affect your family.

Start Free Recall Tracking How Recall Alerts Work

Learn more about the baby product recall tracker, baby product recall alerts, or recall monitoring plans.